Overview

Study to Evaluate the Safety and Antipsoriatic Efficacy of BOS-475 in a Psoriasis Plaque Test

Status:
Completed
Trial end date:
2020-03-06
Target enrollment:
Participant gender:
Summary
This study is being conducted to evaluate the safety of topical BOS-475 compared to topically applied comparator formulations and vehicle.
Phase:
Phase 1
Details
Lead Sponsor:
Boston Pharmaceuticals
Treatments:
Betamethasone
Betamethasone benzoate
Betamethasone sodium phosphate
Betamethasone Valerate
Betamethasone-17,21-dipropionate
Calcipotriene